Traws Pharma Inc (TRAW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 226 | 226 | 226 | 226 | 231 |
| Gross Profit | 226 | 226 | 226 | 226 | 231 |
| Operating Expenses | 142,600 | 20,524 | 19,853 | 16,722 | 25,224 |
| Operating Income | -142,374 | -20,298 | -19,627 | -16,496 | -24,993 |
| Other Income | -24,149 | 1,350 | 663 | 333 | -160 |
| Pre-tax Income | -166,523 | -18,948 | -18,964 | -16,163 | -25,153 |
| Income Tax | N/A | N/A | N/A | N/A | 4 |
| Net Income Continuous | -166,523 | -18,948 | -18,964 | -16,163 | -25,157 |
| Net Income | $-166,523 | $-18,948 | $-18,964 | $-16,163 | $-25,157 |
| EPS Basic Total Ops | -35.21 | -22.57 | -22.75 | -24.00 | -54.25 |
| EPS Basic Continuous Ops | -107.25 | -22.57 | -22.68 | -24.01 | -54.21 |
| EPS Diluted Total Ops | -35.21 | -22.57 | -22.75 | -24.00 | -54.25 |
| EPS Diluted Continuous Ops | -107.25 | -22.57 | -22.68 | -24.01 | -54.21 |
| EPS Diluted Before Non-Recurring Items | -35.21 | -22.50 | -22.75 | -24.00 | -52.47 |
| EBITDA(a) | $-142,362 | $-20,282 | $-19,613 | $-16,482 | $-24,980 |